恶性脑肿瘤开颅术后30天和90天再入院的预测因素:全国数据分析
该研究利用2013至2014年全国再入院数据库(NRD),纳入27,717例因原发性和继发性恶性脑肿瘤行开颅术的成人住院患者,分析患者、医院和支付方因素与30天和90天再入院的关联。结果显示30天再入院3343例(13.2%),90天再入院5271例(25.7%);医疗补助(Medicaid)和医疗保险(Medicare)患者、有两种及以上合并症的患者再入院可能性更高,出院至专业护理机构或家庭健康护理与90天再入院率升高相关,医院手术量高于第75百分位与90天再入院率降低相关。
要点
- 30天再入院3343例(13.2%),90天再入院5271例(25.7%)。
- 医疗补助和医疗保险患者较私人保险患者30天和90天再入院可能性更高。
- 有两种及以上合并症患者30天和90天再入院可能性更高。
核心结论
- 在高手术量医院治疗的患者90天再入院可能性更低。
- 保险类型、非routine出院和患者合并症是术后非计划再入院的预测因素。
- 进一步研究可能阐明在改善脑肿瘤手术结局和降低成本时可干预的风险因素。
研究设计与样本
- 利用2013至2014年全国再入院数据库(NRD)的全国数据分析。
- 纳入所有因原发性和继发性恶性脑肿瘤行开颅术的成人住院患者。
- 识别开颅术后30天和90天内全因再入院,排除计划性化疗操作。
- 采用单因素和多因素模型识别与再入院相关的患者、医院和行政因素。
主要发现
- 2013至2014年共识别27,717例脑肿瘤开颅术入院,30天再入院3343例(13.2%),90天再入院5271例(25.7%)。
- 多因素分析中,医疗补助和医疗保险患者较私人保险患者30天和90天再入院可能性更高。
- 有两种及以上合并症的患者30天和90天再入院可能性更高。
- 出院至专业护理机构或家庭健康护理与90天再入院率升高相关。
- 医院手术量高于第75百分位与90天再入院率降低相关。
关键数值与推荐
- 30天再入院3343例(13.2%)。
- 90天再入院5271例(25.7%)。
- 医院手术量高于第75百分位与90天再入院率降低相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Hospital readmissions are a major contributor to increased health care costs and are associated with worse patient outcomes after neurosurgery. We used the newly released Nationwide Readmissions Database (NRD) to describe the association between patient, hospital and payer factors with 30- and 90-day readmission following craniotomy for malignant brain tumor. All adult inpatients undergoing craniotomy for primary and secondary malignant brain tumors in the NRD from 2013 to 2014 were included. We identified all cause readmissions within 30- and 90-days following craniotomy for tumor, excluding scheduled chemotherapeutic procedures. We used univariate and multivariate models to identify patient, hospital and administrative factors associated with readmission. We identified 27,717 admissions for brain tumor craniotomy in 2013-2014, with 3343 (13.2%) 30-day and 5271 (25.7%) 90-day readmissions. In multivariate analysis, patients with Medicaid and Medicare were more likely to be readmitted at 30- and 90-days compared to privately insured patients. Patients with two or more comorbidities were more likely to be readmitted at 30- and 90-days, and patients discharged to skilled nursing facilities or home health care were associated with increased 90-day readmission rates. Finally, hospital procedural volume above the 75th percentile was associated with decreased 90-day readmission rates. Patients treated at high volume hospitals are less likely to be readmitted at 90-days. Insurance type, non-routine discharge and patient comorbidities are predictors of postoperative non-scheduled readmission. Further studies may elucidate potentially modifiable risk factors when attempting to improve outcomes and reduce cost associated with brain tumor surgery.
引用
- Donoho DA, Wen T, Babadjouni RM, et al. Predictors of 30- and 90-day readmission following craniotomy for malignant brain tumors: analysis of nationwide data. J Neurooncol. 2017. PMID: 28988350. doi:10.1007/s11060-017-2625-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。